Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Raven

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature|May 25, 2007
Endowments are necessary for museums to thriveD James Baker, Jeremy A Sabloff, Peter A Raven
Hormones and Behavior|August 1, 2008
Disruption of seasonality in growth hormone-transgenic coho salmon (Oncorhynchus kisutch) and the role of cholecystokinin in seasonal feeding behaviorMare Lõhmus, Peter A Raven, L Fredrik Sundström, et al.
Translational Andrology and Urology|April 13, 2018
Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patientsZheng Tan, Ninadh M D'Costa, Peter A Raven, et al.
American Journal of Clinical and Experimental Urology|January 31, 2019
Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) modelPeter A Raven, Ninadh M D'Costa, Igor Moskalev, et al.
International Journal of Cancer|February 26, 2011
The importance of integrin-linked kinase in the regulation of bladder cancer invasionYoshiyuki Matsui, Kiran Assi, Osamu Ogawa, et al.
Molecular Cancer Therapeutics|February 7, 2015
Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell CarcinomaKyung Seok Han, Na Li, Peter A Raven, et al.
Neoplasia (New York, N.Y.)|December 19, 2015
Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell CarcinomaKyung Seok Han, Peter A Raven, Sebastian Frees, et al.
Journal of Cellular Physiology|April 24, 2019
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancerPeter A Raven, Summer Lysakowski, Zheng Tan, et al.
The Prostate|August 9, 2017
Magnetically-actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot studyWerner J Struss, Zheng Tan, Payam Zachkani, et al.
Biomaterials|October 22, 2011
Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urotheliumClement Mugabe, Peter A Raven, Ladan Fazli, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature|May 25, 2007
Endowments are necessary for museums to thriveD James Baker, Jeremy A Sabloff, Peter A Raven
Hormones and Behavior|August 1, 2008
Disruption of seasonality in growth hormone-transgenic coho salmon (Oncorhynchus kisutch) and the role of cholecystokinin in seasonal feeding behaviorMare Lõhmus, Peter A Raven, L Fredrik Sundström, et al.
Translational Andrology and Urology|April 13, 2018
Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patientsZheng Tan, Ninadh M D'Costa, Peter A Raven, et al.
American Journal of Clinical and Experimental Urology|January 31, 2019
Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) modelPeter A Raven, Ninadh M D'Costa, Igor Moskalev, et al.
International Journal of Cancer|February 26, 2011
The importance of integrin-linked kinase in the regulation of bladder cancer invasionYoshiyuki Matsui, Kiran Assi, Osamu Ogawa, et al.
Molecular Cancer Therapeutics|February 7, 2015
Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell CarcinomaKyung Seok Han, Na Li, Peter A Raven, et al.
Neoplasia (New York, N.Y.)|December 19, 2015
Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell CarcinomaKyung Seok Han, Peter A Raven, Sebastian Frees, et al.
Journal of Cellular Physiology|April 24, 2019
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancerPeter A Raven, Summer Lysakowski, Zheng Tan, et al.
The Prostate|August 9, 2017
Magnetically-actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot studyWerner J Struss, Zheng Tan, Payam Zachkani, et al.
Biomaterials|October 22, 2011
Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urotheliumClement Mugabe, Peter A Raven, Ladan Fazli, et al.
Pageof 2